The study employed a sophisticated computer modeling platform built in response to the COVID-19 pandemic.
Dr. Stracher will provide clinical leadership and direction on policies and programs that impact the health of faculty, staff, students, board members, and patients at Weill Cornell Medicine.
Dr. Cristofanilli's many scientific advances in the field of breast cancer include novel biomarkers (endocrine), findings on circulating tumor cells, and drug development with a focus on endocrine therapy.
PGD is a syndrome in which people feel stuck in a cycle of mourning that can last for years or even decades. This ongoing cycle can impair an individual’s daily life, relationships, and job performance.
First held in 2012, the event showcases quality and safety projects from all departments across the Weill Cornell uptown, Lower Manhattan, Queens, and Brooklyn Methodist locations.
Dr. Julianne Imperato-McGinley is leading an effort to help make vaccination for COVID-19 available in trusted spaces within people’s own neighborhoods. It is estimated that 70 to 90% of the population needs to be vaccinated to reach herd immunity.
Investigators at Weill Cornell Medicine and NewYork-Presbyterian are recruiting 1,000 asymptomatic health care workers for a study on COVID-19 that seeks to answer the question: why do some people become severely ill, while others have no symptoms?
The event recognized the accomplishments of the QIA graduates and their ongoing commitment to improving patient care across the institution. Despite the many setbacks due to COVID-19, 10 projects were completed this year.
The Department of Nursing gives the Physician of the Year Award to recognize physicians who consistently practice with nursing and support staff in a collaborative, collegial, and respectful manner.
Until now, vital data had been lacking on graft and patient outcomes in kidney transplant recipients and the management of their immunosuppression in the setting of Covid-19.